Skip to main content

Table 1 Demographic, clinical, and genotypic profiles of patients

From: Relationship of gene polymorphisms for complement components C3 and factor H and kidney allograft function

Pretransplant variable

N = 73

Gender, male, n (%)

51 (69.9)

Age (years), mean ± SD

46.9 ± 10.9

Positive PRA (5–30%), n (%)

5 (6.8)

Genotype, n (%)

FH (rs800292)

GG, n (%)

52 (71.8)

GA, n (%)

21 (28.8)

AA, n (%)

0 (0.0)

C3 (rs2230199)

CC, n (%)

52 (71.2)

GC, n (%)

19 (26.0)

GG, n (%)

2 (2.7)

Etiology of CKD, n (%)

 

NSCL, n (%)

25 (34.2)

GN, n (%)

18 (24.7)

TIN, n (%)

4 (5.5)

PKD, n (%)

10 (13.7)

Other, n (%)

22 (30.2)

Comorbidities, n (%)

 

HTN, n (%)

58 (79.5)

CMP, n (%)

1 (1.4)

Ischemic coronary heart disease, n (%)

1 (1.4)

CVI, n (%)

1 (1.4)

  1. PRA: panel reactive antibodies, CKD: chronic kidney disease, NSCL: nephroangiosclerosis, GN: glomerulonephritis, TIN: tubulointerstitial nephritis, PKD: polycystic kidney disease, HTN: hypertension, CMP: cardiomyopathy, CVI: cerebrovascular insult